Senhwa Biosciences, Inc. (TPEX:6492)
Taiwan · Delayed Price · Currency is TWD 44.40
-0.50 (-1.11%)
At close: Jul 9, 2026
Senhwa Biosciences Market Cap
Senhwa Biosciences has a market cap or net worth of 4.01 billion as of July 9, 2026. Its market cap has increased by 30.44% in one year.
Market Cap
4.01B
Enterprise Value
3.35B
Revenue
1.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
44.40
Market Cap Chart
Since December 4, 2014, Senhwa Biosciences's market cap has decreased from 6.81B to 4.01B, a decrease of -41.08%. That is a compound annual growth rate of -4.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 4.01B | 2.27% |
| Dec 31, 2025 | 3.92B | 1.15% |
| Dec 31, 2024 | 3.88B | -14.54% |
| Dec 29, 2023 | 4.54B | -11.69% |
| Dec 30, 2022 | 5.14B | -44.90% |
| Dec 30, 2021 | 9.33B | -53.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinew Pharma | 5.08B |
| Steminent Biotherapeutics | 4.99B |
| Pharmosa Biopharm | 4.90B |
| OBI Pharma | 3.89B |
| Genovate Biotechnology | 3.74B |
| Formosa Pharmaceuticals | 3.67B |
| Sagittarius Life Science | 3.52B |
| SYN-TECH Chem. & Pharm. | 3.36B |